SCHEMBL21717026

SCHEMBL21717026

c1ccc(-c2nc3ccccc3nc2-c2ccc3cc(-n4c5ccc(-n6c7ccccc7c7c8ccccc8ccc76)cc5c5cc6ccccc6cc54)ccc3c2)cc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 5/20 0.34
ALDH1A1 P00352 4/20 0.34
L3MBTL1 Q9Y468 3/20 0.34
KDM4E B2RXH2 3/20 0.34
TDP1 Q9NUW8 2/20 0.34
NPSR1 Q6W5P4 1/20 0.34
ADORA2A P29274 1/20 0.34
ADORA1 P30542 1/20 0.34
THRB P10828 1/20 0.34
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
GAA P10253 2/20 0.34
HPGD P15428 3/20 0.33
POLB P06746 2/20 0.33
HSD17B10 Q99714 1/20 0.33
PTGES O14684 1/20 0.33
MAPK8 P45983 1/20 0.33
MAPK9 P45984 1/20 0.33
MAPK10 P53779 1/20 0.33
NPY5R Q15761 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21716254 0.97 ADORA2A (0.35) LMNAALDH1A1L3MBTL1KDM4ETDP1
SCHEMBL21717027 0.96 HPGD (0.34) LMNAALDH1A1KDM4EADORA2AADORA1
SCHEMBL21716240 0.96 L3MBTL1 (0.36) LMNAALDH1A1L3MBTL1KDM4ETDP1
SCHEMBL21716255 0.95 HPGD (0.32) LMNAALDH1A1L3MBTL1KDM4ETDP1
SCHEMBL21716237 0.95 MAPK10 (0.36) LMNAALDH1A1L3MBTL1KDM4EADORA2A
SCHEMBL21716897 0.95 L3MBTL1 (0.35) LMNAALDH1A1L3MBTL1KDM4ETDP1
SCHEMBL21717042 0.92 L3MBTL1 (0.38) LMNAALDH1A1L3MBTL1KDM4ETDP1
SCHEMBL21716813 0.92 L3MBTL1 (0.38) LMNAALDH1A1L3MBTL1KDM4ETDP1
SCHEMBL21716892 0.92 L3MBTL1 (0.33) LMNAALDH1A1L3MBTL1KDM4ETDP1
SCHEMBL21716703 0.92 KDM4E (0.36) LMNAL3MBTL1KDM4EGAAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11192884-B2 Heterocyclic compound and organic light-emitting device comprising same LG CHEM, LTD. (KR) 2021-12-07 US disclosed
US-20200048226-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LG CHEM, LTD. (KR) 2020-02-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11192884-B2 Heterocyclic compound and organic light-emitting device comprising same CYP1A1, CYP1B1, CRY1 LMNA 2047/4885ALDH1A1 33/4885L3MBTL1 1427/4885
US-20200048226-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME CYP1A1, CYP1B1, CRY1 LMNA 2047/4885ALDH1A1 33/4885L3MBTL1 1427/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.